Next Article in Journal
AP-2 Transcription Factors as Regulators of Ferroptosis: A Family-Wide Profiling in Diverse Cancer Contexts
Next Article in Special Issue
Stalling the Enemy: Targeting Nsp13 for Next-Generation SARS-CoV-2 Antivirals
Previous Article in Journal
Transcription Factor–Based Classification of Pituitary Neuroendocrine Tumors: Practical Immunohistochemical Algorithms, Molecular Correlates, and Diagnostic Challenges in the 5th WHO Era
Previous Article in Special Issue
Optimization of SARS-CoV-2 Mpro Inhibitors by a Structure-Based Multilevel Virtual Screening Method
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors

1
Department of Medicine, Surgery and Pharmacy, University of Sassari, 07100 Sassari, Italy
2
Centro Retrovirus, Department of Translational Research, University of Pisa, 56127 Pisa, Italy
3
Department of Chemical, Physical, Mathematical and Natural Sciences, University of Sassari, 07100 Sassari, Italy
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2026, 27(5), 2306; https://doi.org/10.3390/ijms27052306
Submission received: 26 January 2026 / Revised: 21 February 2026 / Accepted: 27 February 2026 / Published: 28 February 2026
(This article belongs to the Special Issue Antiviral Drugs Discovery)

Abstract

A small library of 23 pyrrole-based tricyclic derivatives bearing bulky amine moieties was synthesized, and all were evaluated for their antiviral activities against ZIKV and SARS-CoV. Three compounds, derivatives 2g, 2h and 2j, elicited interesting activity against ZIKV: compound 2g, containing a bornylamine residue, showed the best activity against Huh-7 cells with EC50 and CC50 values of 0.4 μM and 230.5 μM, respectively, and a Selectivity Index (SI) of 501. All three compounds reduce ZIKV yield primarily by impairing viral protein.
Keywords: synthesis of tricyclic pyrroles; antiviral activity; Western blot analysis synthesis of tricyclic pyrroles; antiviral activity; Western blot analysis

Share and Cite

MDPI and ACS Style

Murineddu, G.; Plicanti, E.; Corona, P.; Di Marzo, C.; Asproni, B.; Lupinu, I.; Lottini, G.; Piras, S.; Carta, A. Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors. Int. J. Mol. Sci. 2026, 27, 2306. https://doi.org/10.3390/ijms27052306

AMA Style

Murineddu G, Plicanti E, Corona P, Di Marzo C, Asproni B, Lupinu I, Lottini G, Piras S, Carta A. Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors. International Journal of Molecular Sciences. 2026; 27(5):2306. https://doi.org/10.3390/ijms27052306

Chicago/Turabian Style

Murineddu, Gabriele, Erika Plicanti, Paola Corona, Carlo Di Marzo, Battistina Asproni, Ilenia Lupinu, Giulia Lottini, Sandra Piras, and Antonio Carta. 2026. "Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors" International Journal of Molecular Sciences 27, no. 5: 2306. https://doi.org/10.3390/ijms27052306

APA Style

Murineddu, G., Plicanti, E., Corona, P., Di Marzo, C., Asproni, B., Lupinu, I., Lottini, G., Piras, S., & Carta, A. (2026). Tricyclic Pyrrole-Based Compounds as Zika Virus Inhibitors. International Journal of Molecular Sciences, 27(5), 2306. https://doi.org/10.3390/ijms27052306

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop